HUMA – humacyte, inc. (US:NASDAQ)
Stock Stats
News
Humacyte (NASDAQ:HUMA) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Humacyte (NASDAQ:HUMA) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Humacyte (HUMA) Q3 2025 Earnings Call Transcript [Yahoo! Finance]
Humacyte (NASDAQ:HUMA) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $6.00 price target on the stock.
Humacyte (NASDAQ:HUMA) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $25.00 price target on the stock.
Form 8-K Humacyte, Inc. For: Nov 21
Form 4 Humacyte, Inc. For: Nov 16 Filed by: Sander Dale A.
Form 4 Humacyte, Inc. For: Nov 16 Filed by: Parikh Shamik J
Form 4 Humacyte, Inc. For: Nov 16 Filed by: Dougan Brady W
Form 4 Humacyte, Inc. For: Nov 16 Filed by: Niklason Laura E
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.